Semaglutide treatment for obesity in adults (STEP 1 trial)
study004
10.1056/NEJMoa2032183
New England Journal of Medicine
randomized clinical trial
Semaglutide evaluated for chronic weight management in non-diabetic adults.
Participants experienced substantial weight reduction relative to placebo.
semaglutide
fat-loss|metabolism
metabolic-stack
semaglutide-vs-tirzepatide
published